These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7104186)

  • 1. Plasma protein binding of phenytoin in 100 epileptic patients.
    Peterson GM; McLean S; Aldous S; Von Witt RJ; Millingen KS
    Br J Clin Pharmacol; 1982 Aug; 14(2):298-300. PubMed ID: 7104186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.
    Barth N; Alván G; Borgå O; Sjöqvist F
    Clin Pharmacokinet; 1976; 1(6):444-52. PubMed ID: 1024769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should we routinely measure free plasma phenytoin concentration?
    Rimmer EM; Buss DC; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jan; 17(1):99-102. PubMed ID: 6419764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of unbound phenytoin in the management of epilepsy.
    Kilpatrick CJ; Wanwimolruk S; Wing LM
    Br J Clin Pharmacol; 1984 May; 17(5):539-46. PubMed ID: 6733002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical response in epilepsy in relation to total and free serum levels of phenytoin.
    Peterson GM; Khoo BH; von Witt RJ
    Ther Drug Monit; 1991 Sep; 13(5):415-9. PubMed ID: 1957333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafiltration compared with equilibrium dialysis in the determination of unbound phenytoin in plasma.
    Koike Y; Magnusson A; Steiner E; Rane A; Sjöqvist F
    Ther Drug Monit; 1985; 7(4):461-5. PubMed ID: 3909538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased plasma protein binding of phenytoin in patients on valproic acid.
    Dahlqvist R; Borgå O; Rane A; Walsh Z; Sjöqvist F
    Br J Clin Pharmacol; 1979 Dec; 8(6):547-52. PubMed ID: 391256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of plasma unbound drug concentrations in adjusting phenytoin doses.
    Bachmann K; Voeller K; Forney R
    Ther Drug Monit; 1984; 6(2):173-8. PubMed ID: 6740736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.
    Oellerich M; Müller-Vahl H
    Clin Pharmacokinet; 1984 Jan; 9 Suppl 1():61-70. PubMed ID: 6705428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated determination of free phenytoin in human plasma with on-line equilibrium dialysis and column-switching high-performance liquid chromatography.
    Andresen AT; Rasmussen KE; Rugstad HE
    J Chromatogr; 1993 Nov; 621(2):189-98. PubMed ID: 8294541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is free fraction measurement of phenytoin always necessary in pediatric epileptic patients?
    Johno I; Kuzuya T; Suzuki K; Hasegawa M; Nakamura T; Kitazawa S; Aso K; Watanabe K
    Ther Drug Monit; 1988; 10(1):39-44. PubMed ID: 3376180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring phenytoin in salivary and plasma ultrafiltrates of pediatric patients.
    Bachmann K; Forney RB; Voeller K
    Ther Drug Monit; 1983; 5(3):325-9. PubMed ID: 6636260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unbound phenytoin plasma concentrations in patients comedicated with sodium valproate--the predictive value of plasma albumin concentration.
    Johnson GJ; Kilpatrick CJ; Bury RW; Fullinfaw RO; Moulds RF
    Br J Clin Pharmacol; 1989 Jun; 27(6):843-9. PubMed ID: 2503019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variability of phenytoin protein binding in epileptic patients.
    DeMonaco HJ; Lawless LM
    Arch Neurol; 1983 Aug; 40(8):481-3. PubMed ID: 6347141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting unbound phenytoin concentrations in patients receiving valproic acid: a comparison of two prediction methods.
    Kerrick JM; Wolff DL; Graves NM
    Ann Pharmacother; 1995 May; 29(5):470-4. PubMed ID: 7655129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of valproate on free plasma phenytoin concentrations.
    Tsanaclis LM; Allen J; Perucca E; Routledge PA; Richens A
    Br J Clin Pharmacol; 1984 Jul; 18(1):17-20. PubMed ID: 6430316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged impairment of the plasma-protein binding of phenytoin in the rat after a single dose of sodium oleate.
    Colburn WA; Gibaldi M
    Drug Metab Dispos; 1978; 6(4):452-5. PubMed ID: 28926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temperature effect on serum protein binding kinetics of phenytoin in monotherapy patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Todaka K; Mitsuyama Y
    Eur J Pharm Biopharm; 1999 May; 47(3):295-8. PubMed ID: 10382115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo binding characteristics of phenytoin to serum proteins in monotherapy pediatric patients with epilepsy.
    Kodama H; Kodama Y; Shinozawa S; Kanemaru R; Itokazu N; Sugimoto T
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):25-9. PubMed ID: 10667833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.